ClinicalTrials.Veeva

Menu

Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors

Fred Hutchinson Cancer Center (FHCC) logo

Fred Hutchinson Cancer Center (FHCC)

Status and phase

Completed
Phase 2

Conditions

Prognostic Stage IA Breast Cancer AJCC v8
Prognostic Stage IB Breast Cancer AJCC v8
Prognostic Stage I Breast Cancer AJCC v8
Prognostic Stage IIB Breast Cancer AJCC v8
Prognostic Stage IIA Breast Cancer AJCC v8
Prognostic Stage IIIC Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Prognostic Stage III Breast Cancer AJCC v8
Prognostic Stage 0 Breast Cancer AJCC v8
Anatomic Stage IIB Breast Cancer AJCC v8
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage 0 Breast Cancer AJCC v8
Anatomic Stage IIIA Breast Cancer AJCC v8
Prognostic Stage IIIB Breast Cancer AJCC v8
Prognostic Stage IIIA Breast Cancer AJCC v8
Anatomic Stage IIIB Breast Cancer AJCC v8
Anatomic Stage IIIC Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Prognostic Stage II Breast Cancer AJCC v8
Anatomic Stage IB Breast Cancer AJCC v8
Anatomic Stage IA Breast Cancer AJCC v8

Treatments

Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Behavioral: One Diet and Physical Activity Session
Other: Electronic (e) Health (eHealth) Communication Intervention
Behavioral: Twelve Diet and Physical Activity Group Sessions

Study type

Interventional

Funder types

Other

Identifiers

NCT04200482
RG1006427
10335 (Other Identifier)
NCI-2019-07643 (Registry Identifier)

Details and patient eligibility

About

The purpose of this phase II trial is to identify the most effective dose level (number of classes) of a diet and physical activity lifestyle program based on how well it improves diet and physical activity in stage 0-III breast cancer survivors. Study results may provide researchers with information on how to best implement diet and physical activity recommendations among breast cancer survivors.

Full description

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM A (LOW DOSE): Participants attend one diet and physical activity class delivered remotely via Zoom and receive an eHealth communication intervention for 6 months.

ARM B (HIGH DOSE): Participants attend 12 twice monthly diet and physical activity online sessions delivered remotely via Zoom and receive an eHealth communication intervention for 6 months.

Enrollment

90 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Previous diagnosis of stage 0-III breast cancer in the past 10 years at the time of enrollment
  • No evidence of recurrent or metastatic disease
  • No uncontrolled diabetes mellitus defined as glycosylated hemoglobin (Hgb A1C) > 8%
  • No uncontrolled hypertension per Seattle Cancer Care Alliance (SCCA) standard of care
  • At least 60 days post final chemotherapy, biologic therapy, or radiation therapy and/or surgery. Current use of endocrine therapy is permitted (e.g., tamoxifen and aromatase inhibitors)
  • Access to phone for study contacts
  • Access to smartphone, tablet, or computer and internet to attend online session(s) and receive study electronic eHealth communication (text messages and access to website)
  • Willing and able to attend the online session(s) on Saturdays, or via online accessed videos, for up to 12 sessions in 6 months
  • Successfully complete all run-in activities, including at-home and over the phone assessments, 7 days of collecting physical activity data via accelerometer, and providing blood and stool sample
  • Willing and able to complete all study activities for 6 months after randomization
  • Participants must consume < 5 servings of fruits and vegetables per day and/or engage in < 150 minutes per week of moderate to vigorous physical activity, as assessed by brief questionnaires
  • Participants must have an Eastern Cooperative Oncology Group (ECOG) Scale of performance status score of 0 or 1 for performance status.
  • Signed physician approval for diet change and physical activity
  • Able to understand and willing to sign written informed electronic (e) consent in English

Exclusion criteria

  • Participants must not be active smokers within the past 30 days.
  • Women must not be pregnant at time of enrollment

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 2 patient groups

Arm A (low dose nutrition and PA class, eHealth intervention)
Active Comparator group
Description:
Participants attend one diet and physical activity class delivered remotely via Zoom and receive an eHealth communication intervention for 6 months.
Treatment:
Other: Questionnaire Administration
Other: Electronic (e) Health (eHealth) Communication Intervention
Behavioral: One Diet and Physical Activity Session
Other: Quality-of-Life Assessment
Arm B (high dose nutrition and PA class, eHealth intervention)
Experimental group
Description:
Participants attend 12 twice monthly diet and physical activity online sessions delivered remotely via Zoom and receive an eHealth communication intervention for 6 months.
Treatment:
Other: Questionnaire Administration
Behavioral: Twelve Diet and Physical Activity Group Sessions
Other: Electronic (e) Health (eHealth) Communication Intervention
Other: Quality-of-Life Assessment

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems